|
Recent Developments |
|
09-MAY-17
Ahmedabad based Torrent Pharma announced that it has completed the acquisition of Regestrone and Pregachieve brands for India from global Pharma player Novartis AG. Switzerland.
12-APR-17
Torrent Pharmaceuticals, one of the leading pharma companies of the country, has entered into agreement with Novartis AG to acquire certain generic drugs. The closure of the deal is subject to the approval of Competition Commission of India (CCI) an... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Period ending (months) | 31-Dec-2017(9) | 31-Mar-2017(12) | 31-Mar-2016(12) | | Net sales | 29010.00 | 45010.00 | 52800.00 | | Other Income | 2810.00 | 2990.00 | 2770.00 | | Total Income | 31820.00 | 48000.00 | 55570.00 | | Cost of goods sold | 24750.00 | 37250.00 | 27890.00 | | OPBDIT | 7070.00 | 10750.00 | 27680.00 | | PAT | 2620.00 | 8540.00 | 18980.00 | | Gross Block | - | - | - | | Equity capital | - | - | 850.00 | | EPS (Rs.) | - | - | - | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | - | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 22.2 | 22.4 | 49.8 | | Net margin (% of OI) | 8.2 | 17.8 | 34.2 |
|
|
Detailed Financials
|
|
|
|
|
